nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—atherosclerosis	0.404	1	CbGaD
Lumiracoxib—CYP2C19—Rosuvastatin—atherosclerosis	0.0737	0.168	CbGbCtD
Lumiracoxib—CYP2C19—Simvastatin—atherosclerosis	0.0685	0.156	CbGbCtD
Lumiracoxib—CYP2C19—Lovastatin—atherosclerosis	0.067	0.153	CbGbCtD
Lumiracoxib—CYP2C9—Rosuvastatin—atherosclerosis	0.0612	0.14	CbGbCtD
Lumiracoxib—CYP2C9—Simvastatin—atherosclerosis	0.0569	0.13	CbGbCtD
Lumiracoxib—CYP2C9—Lovastatin—atherosclerosis	0.0557	0.127	CbGbCtD
Lumiracoxib—CYP2C9—Pravastatin—atherosclerosis	0.0557	0.127	CbGbCtD
Lumiracoxib—Diclofenac—PLA2G2A—atherosclerosis	0.00235	0.245	CrCbGaD
Lumiracoxib—PTGS2—leg—atherosclerosis	0.00198	0.124	CbGeAlD
Lumiracoxib—PTGS2—hindlimb—atherosclerosis	0.00177	0.111	CbGeAlD
Lumiracoxib—PTGS2—appendage—atherosclerosis	0.00152	0.0954	CbGeAlD
Lumiracoxib—Meclofenamic acid—ALOX5—atherosclerosis	0.0015	0.157	CrCbGaD
Lumiracoxib—Tolmetin—CXCL8—atherosclerosis	0.00126	0.132	CrCbGaD
Lumiracoxib—PTGS1—artery—atherosclerosis	0.00113	0.0713	CbGeAlD
Lumiracoxib—PTGS2—artery—atherosclerosis	0.00108	0.0682	CbGeAlD
Lumiracoxib—Tolmetin—MPO—atherosclerosis	0.000984	0.103	CrCbGaD
Lumiracoxib—PTGS1—endothelium—atherosclerosis	0.000957	0.0602	CbGeAlD
Lumiracoxib—UGT1A9—liver—atherosclerosis	0.000926	0.0583	CbGeAlD
Lumiracoxib—PTGS2—endothelium—atherosclerosis	0.000915	0.0576	CbGeAlD
Lumiracoxib—PTGS1—blood vessel—atherosclerosis	0.000883	0.0555	CbGeAlD
Lumiracoxib—PTGS2—blood vessel—atherosclerosis	0.000844	0.0531	CbGeAlD
Lumiracoxib—Diclofenac—ALOX5—atherosclerosis	0.000841	0.0877	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—atherosclerosis	0.000696	0.0727	CrCbGaD
Lumiracoxib—Bromfenac—PTGS2—atherosclerosis	0.000549	0.0573	CrCbGaD
Lumiracoxib—PTGS1—connective tissue—atherosclerosis	0.000453	0.0285	CbGeAlD
Lumiracoxib—PTGS2—connective tissue—atherosclerosis	0.000433	0.0272	CbGeAlD
Lumiracoxib—CYP2C9—cardiovascular system—atherosclerosis	0.000431	0.0271	CbGeAlD
Lumiracoxib—PTGS1—cardiovascular system—atherosclerosis	0.000394	0.0248	CbGeAlD
Lumiracoxib—PTGS2—cardiovascular system—atherosclerosis	0.000376	0.0237	CbGeAlD
Lumiracoxib—Tolmetin—PTGS2—atherosclerosis	0.000369	0.0385	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—atherosclerosis	0.000364	0.0379	CrCbGaD
Lumiracoxib—PTGS1—adipose tissue—atherosclerosis	0.000347	0.0219	CbGeAlD
Lumiracoxib—CYP2C19—liver—atherosclerosis	0.000344	0.0217	CbGeAlD
Lumiracoxib—PTGS2—adipose tissue—atherosclerosis	0.000332	0.0209	CbGeAlD
Lumiracoxib—Mefenamic acid—PTGS2—atherosclerosis	0.000283	0.0295	CrCbGaD
Lumiracoxib—CYP1A2—liver—atherosclerosis	0.000281	0.0177	CbGeAlD
Lumiracoxib—CYP2C9—liver—atherosclerosis	0.000267	0.0168	CbGeAlD
Lumiracoxib—PTGS2—liver—atherosclerosis	0.000233	0.0146	CbGeAlD
Lumiracoxib—Diclofenac—PTGS2—atherosclerosis	0.000203	0.0212	CrCbGaD
Lumiracoxib—Diclofenac—ALB—atherosclerosis	0.000181	0.0189	CrCbGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.72e-05	0.000206	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FABP4—atherosclerosis	2.71e-05	0.000205	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LCAT—atherosclerosis	2.71e-05	0.000205	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—HMOX1—atherosclerosis	2.7e-05	0.000205	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PARP1—atherosclerosis	2.66e-05	0.000202	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOA4—atherosclerosis	2.66e-05	0.000202	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.65e-05	0.000201	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NAMPT—atherosclerosis	2.64e-05	0.0002	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.62e-05	0.000199	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—LIPC—atherosclerosis	2.62e-05	0.000199	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.61e-05	0.000198	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.61e-05	0.000198	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOC3—atherosclerosis	2.6e-05	0.000197	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.6e-05	0.000197	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.59e-05	0.000196	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—LDLR—atherosclerosis	2.59e-05	0.000196	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOB—atherosclerosis	2.59e-05	0.000196	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ABCA1—atherosclerosis	2.57e-05	0.000195	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.54e-05	0.000193	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CETP—atherosclerosis	2.53e-05	0.000192	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTM1—atherosclerosis	2.52e-05	0.000191	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOA2—atherosclerosis	2.51e-05	0.00019	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.51e-05	0.00019	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.51e-05	0.00019	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.51e-05	0.00019	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.49e-05	0.000189	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.48e-05	0.000188	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.48e-05	0.000188	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.48e-05	0.000188	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—LPL—atherosclerosis	2.47e-05	0.000187	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCG1—atherosclerosis	2.46e-05	0.000187	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SCARB1—atherosclerosis	2.42e-05	0.000184	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.41e-05	0.000183	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GPX1—atherosclerosis	2.41e-05	0.000183	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LPA—atherosclerosis	2.39e-05	0.000182	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.38e-05	0.00018	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.36e-05	0.000179	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CD36—atherosclerosis	2.35e-05	0.000178	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BGN—atherosclerosis	2.32e-05	0.000176	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.32e-05	0.000176	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FABP4—atherosclerosis	2.31e-05	0.000176	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LCAT—atherosclerosis	2.31e-05	0.000176	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.3e-05	0.000175	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOA5—atherosclerosis	2.3e-05	0.000174	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.29e-05	0.000174	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOA2—atherosclerosis	2.29e-05	0.000174	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.29e-05	0.000174	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.29e-05	0.000174	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HMGCR—atherosclerosis	2.29e-05	0.000173	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOA4—atherosclerosis	2.27e-05	0.000172	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.26e-05	0.000171	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.26e-05	0.000171	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP7A1—atherosclerosis	2.23e-05	0.000169	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.23e-05	0.000169	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—atherosclerosis	2.22e-05	0.000169	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.21e-05	0.000168	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—HMOX1—atherosclerosis	2.2e-05	0.000167	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.19e-05	0.000166	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LPA—atherosclerosis	2.18e-05	0.000166	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARA—atherosclerosis	2.18e-05	0.000165	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.16e-05	0.000164	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.16e-05	0.000164	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.13e-05	0.000162	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.13e-05	0.000161	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BGN—atherosclerosis	2.11e-05	0.00016	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AGT—atherosclerosis	2.11e-05	0.00016	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOB—atherosclerosis	2.11e-05	0.00016	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.1e-05	0.000159	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOA5—atherosclerosis	2.09e-05	0.000159	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOE—atherosclerosis	2.07e-05	0.000157	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP27A1—atherosclerosis	2.06e-05	0.000156	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTM1—atherosclerosis	2.05e-05	0.000156	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CAV1—atherosclerosis	2.05e-05	0.000156	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOA1—atherosclerosis	2.05e-05	0.000155	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCA1—atherosclerosis	2.04e-05	0.000154	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.03e-05	0.000154	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.03e-05	0.000154	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.02e-05	0.000153	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—LPL—atherosclerosis	2.01e-05	0.000153	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOB—atherosclerosis	2e-05	0.000152	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.99e-05	0.000151	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.98e-05	0.00015	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.97e-05	0.00015	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.97e-05	0.00015	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.97e-05	0.000149	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GPX1—atherosclerosis	1.96e-05	0.000149	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOA2—atherosclerosis	1.96e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.96e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.96e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.96e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.95e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.93e-05	0.000147	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.93e-05	0.000146	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.91e-05	0.000145	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CD36—atherosclerosis	1.91e-05	0.000145	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LPL—atherosclerosis	1.91e-05	0.000145	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.9e-05	0.000144	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LIPC—atherosclerosis	1.9e-05	0.000144	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOC3—atherosclerosis	1.89e-05	0.000143	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LDLR—atherosclerosis	1.88e-05	0.000143	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CG—atherosclerosis	1.87e-05	0.000142	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LPA—atherosclerosis	1.87e-05	0.000142	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRKCG—atherosclerosis	1.86e-05	0.000141	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CETP—atherosclerosis	1.84e-05	0.000139	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—atherosclerosis	1.81e-05	0.000137	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BGN—atherosclerosis	1.81e-05	0.000137	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—atherosclerosis	1.8e-05	0.000137	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.8e-05	0.000136	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.79e-05	0.000136	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOA5—atherosclerosis	1.79e-05	0.000136	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARA—atherosclerosis	1.78e-05	0.000135	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—INS—atherosclerosis	1.77e-05	0.000134	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.76e-05	0.000133	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HMOX1—atherosclerosis	1.75e-05	0.000133	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.75e-05	0.000132	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.74e-05	0.000132	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.74e-05	0.000132	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LIPC—atherosclerosis	1.73e-05	0.000132	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOC3—atherosclerosis	1.72e-05	0.000131	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AGT—atherosclerosis	1.72e-05	0.000131	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.72e-05	0.000131	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—atherosclerosis	1.72e-05	0.00013	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LDLR—atherosclerosis	1.71e-05	0.00013	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.71e-05	0.00013	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.7e-05	0.000129	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOE—atherosclerosis	1.69e-05	0.000128	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.69e-05	0.000128	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.68e-05	0.000128	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOB—atherosclerosis	1.67e-05	0.000127	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CETP—atherosclerosis	1.67e-05	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFB—atherosclerosis	1.67e-05	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAV1—atherosclerosis	1.67e-05	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOA1—atherosclerosis	1.67e-05	0.000127	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.66e-05	0.000126	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.66e-05	0.000126	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—atherosclerosis	1.63e-05	0.000123	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—atherosclerosis	1.62e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.6e-05	0.000122	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOE—atherosclerosis	1.6e-05	0.000121	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—LPL—atherosclerosis	1.6e-05	0.000121	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CAV1—atherosclerosis	1.59e-05	0.00012	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOA1—atherosclerosis	1.58e-05	0.00012	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.56e-05	0.000118	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPX1—atherosclerosis	1.56e-05	0.000118	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—atherosclerosis	1.55e-05	0.000118	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.54e-05	0.000117	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.52e-05	0.000116	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CD36—atherosclerosis	1.52e-05	0.000115	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.51e-05	0.000115	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.5e-05	0.000114	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.49e-05	0.000113	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—atherosclerosis	1.49e-05	0.000113	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.48e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LIPC—atherosclerosis	1.48e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.48e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOC3—atherosclerosis	1.47e-05	0.000112	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—atherosclerosis	1.47e-05	0.000111	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LDLR—atherosclerosis	1.46e-05	0.000111	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—INS—atherosclerosis	1.44e-05	0.000109	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—atherosclerosis	1.44e-05	0.000109	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CETP—atherosclerosis	1.43e-05	0.000108	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—atherosclerosis	1.42e-05	0.000108	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARA—atherosclerosis	1.41e-05	0.000107	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.37e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AGT—atherosclerosis	1.37e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—INS—atherosclerosis	1.37e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.37e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.35e-05	0.000102	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOE—atherosclerosis	1.34e-05	0.000102	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.33e-05	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAV1—atherosclerosis	1.33e-05	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOA1—atherosclerosis	1.32e-05	0.0001	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—atherosclerosis	1.32e-05	0.0001	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.29e-05	9.81e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.27e-05	9.63e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—atherosclerosis	1.26e-05	9.59e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SERPINE1—atherosclerosis	1.26e-05	9.52e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOB—atherosclerosis	1.22e-05	9.22e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.21e-05	9.17e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—atherosclerosis	1.2e-05	9.09e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.18e-05	8.97e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—atherosclerosis	1.17e-05	8.85e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.17e-05	8.85e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LPL—atherosclerosis	1.16e-05	8.8e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.16e-05	8.78e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—atherosclerosis	1.16e-05	8.77e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.15e-05	8.74e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—INS—atherosclerosis	1.14e-05	8.68e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPX1—atherosclerosis	1.13e-05	8.59e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOB—atherosclerosis	1.11e-05	8.41e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CD36—atherosclerosis	1.1e-05	8.37e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.08e-05	8.18e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LPL—atherosclerosis	1.06e-05	8.03e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—atherosclerosis	1.05e-05	7.96e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.05e-05	7.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPX1—atherosclerosis	1.03e-05	7.83e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARA—atherosclerosis	1.03e-05	7.78e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CD36—atherosclerosis	1.01e-05	7.63e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—atherosclerosis	1e-05	7.61e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AGT—atherosclerosis	9.93e-06	7.53e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HMOX1—atherosclerosis	9.89e-06	7.5e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOE—atherosclerosis	9.73e-06	7.38e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAV1—atherosclerosis	9.64e-06	7.31e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOA1—atherosclerosis	9.62e-06	7.3e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—atherosclerosis	9.53e-06	7.23e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOB—atherosclerosis	9.47e-06	7.18e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARA—atherosclerosis	9.35e-06	7.09e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—atherosclerosis	9.22e-06	6.99e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AGT—atherosclerosis	9.06e-06	6.87e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LPL—atherosclerosis	9.05e-06	6.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOE—atherosclerosis	8.87e-06	6.73e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPX1—atherosclerosis	8.83e-06	6.69e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAV1—atherosclerosis	8.79e-06	6.67e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CG—atherosclerosis	8.78e-06	6.66e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOA1—atherosclerosis	8.77e-06	6.65e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CD36—atherosclerosis	8.59e-06	6.52e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—atherosclerosis	8.55e-06	6.48e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—atherosclerosis	8.48e-06	6.43e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—INS—atherosclerosis	8.31e-06	6.3e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK3—atherosclerosis	8.17e-06	6.19e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—atherosclerosis	8.14e-06	6.18e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CG—atherosclerosis	8.01e-06	6.07e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARA—atherosclerosis	7.99e-06	6.06e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—atherosclerosis	7.93e-06	6.01e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AGT—atherosclerosis	7.74e-06	5.87e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—atherosclerosis	7.73e-06	5.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—atherosclerosis	7.62e-06	5.78e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOE—atherosclerosis	7.58e-06	5.75e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—INS—atherosclerosis	7.58e-06	5.75e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAV1—atherosclerosis	7.51e-06	5.7e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOA1—atherosclerosis	7.5e-06	5.68e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—atherosclerosis	7.29e-06	5.53e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—atherosclerosis	7.13e-06	5.41e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—atherosclerosis	6.95e-06	5.27e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CG—atherosclerosis	6.84e-06	5.19e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—atherosclerosis	6.67e-06	5.06e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—atherosclerosis	6.65e-06	5.04e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—atherosclerosis	6.6e-06	5.01e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—INS—atherosclerosis	6.48e-06	4.91e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—atherosclerosis	6.08e-06	4.61e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—atherosclerosis	5.97e-06	4.53e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—atherosclerosis	5.94e-06	4.5e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—atherosclerosis	5.81e-06	4.41e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—atherosclerosis	5.68e-06	4.31e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—atherosclerosis	5.51e-06	4.18e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—atherosclerosis	5.2e-06	3.94e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—atherosclerosis	4.61e-06	3.5e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—atherosclerosis	3.35e-06	2.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—atherosclerosis	3.06e-06	2.32e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—atherosclerosis	2.61e-06	1.98e-05	CbGpPWpGaD
